Pretransplant CD4 helper function and interleukin 10 response predict risk of acute kidney graft rejection

Transplantation

Volumn 62, Issue 11, 1996, Pages 1606-1614

  Weimer, Rolf ^a,b   Zipperle, Silvia ^a   Daniel, Volker ^a   Carl, Stefan ^a   Staehler, Gerd ^a   Opelz, Gerhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; GRAFT REJECTION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOPATHOLOGY; KIDNEY GRAFT; MAJOR CLINICAL STUDY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RISK ASSESSMENT;

ACUTE DISEASE; B-LYMPHOCYTES; BLOOD TRANSFUSION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HUMANS; INFECTION; INTERLEUKIN-10; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; PROSPECTIVE STUDIES; RISK FACTORS; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030447605     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199612150-00014     Document Type: Article

References (55)

1. Weimer R, Daniel V, Pomer S, Opelz G. B lymphocyte response as an indicator of acute renal transplant rejection. II. Pretransplant and posttransplant B cell responses of mitogen and donor cell-stimulated cultures. Transplantation 1989; 48: 572.
2. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 227.
3. Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science 1989; 243: 355.
4. Danis VA, Frame GM, Rathjen DA, Brooks PM. Effects of granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-gamma (INF-γ), tumour necrosis factor-alpha (TNF-α) and IL-6 on the production of immunoreactive IL-1 and TNF-α by human monocytes. Clin Exp Immunol 1991; 85: 143.
5. Herrman F, Cannistra SA, Lindemann A, et al. Functional consequences of monocyte IL-2 receptor expression. Induction of IL-1b secretion by IFN-γ, IL-2. J Immunol 1989; 142: 139.
6. Meulders Q, Rondeau E, Delaure F, Lacave R, Sraer JD. Interleukin-2 stimulation of tumor necrosis factor synthesis by peripheral blood mononuclear cells in renal allograft rejection. Transplant Proc 1990; 22(4): 1987.
7. Siegel JP. Effects of interferon-γ on the activation of human T lymphocytes. Cell Immunol 1988; 111: 461.
8. Andrus L, Granelli-Piperno A, Reich E. Cytotoxic T cells both produce and respond to interleukin 2. J Exp Med 1984; 59: 647.
9. Siegel JP, Sharon M, Smith PL, Leonard WJ. The IL-2 receptor B chain (p 70): role in mediating signals for LAK, NK and proliferative activities. Science 1987; 238: 75.
10. Widmer MB, Grabstein KH. Regulation of cytotoxic T-lymphocyte generation by B-cell stimulatory factors. Nature 1987; 326: 795.
11. Halloran PF, Wadgymar A, Autenried P. The regulation of expression of major histocompatibility complex products. Transplantation 1986; 41: 413.
12. Bishop GA, Waugh JA, Hall BM. Expression of HLA antigens on renal tubular cells in culture. II, Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis. Transplantation 1988; 46(2): 303.
13. Furutani Y, Nomura H, Notake M, et al. Cloning and sequencing of the cDNA for human monocytes chemotactic and activating factor (MCAF). Biochem Biophys Res Commun 1989; 159: 249.
14. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989; 169: 1485.
15. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989; 1: 2.
16. Schall TJ, Jongstra J, Bradley BJ, et al. A human T cell specific molecule is a member of a new gene family. J Immunol 1988; 1411: 1018.
17. deWaal-Malefyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major. J Exp Med 1991; 174: 915.
18. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 1992; 148: 3133.
19. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209.
20. De Waal Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993; 150: 4754.
21. Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993; 81: 2964.
22. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243: 1464.
23. Peveri PA, Walz A, Dewald B, Baggiolini M. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med 1988; 167: 1547.
24. Yoshimura TK, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL-1). J Immunol 1987; 139: 788.
25. Issekutz AC, Issekutz TB. Quantitation and kinetics of blood monocyte migration to acute inflammatory reactions, and IL-Ia, tumor necrosis factor-α and INF-γ. J Immunol 1993; 151(4): 2105.
26. Ishikura H, Takahashi C, Kanagawa K, Hirata H, Imai K, Yotshiki T. Cytokine regulation of ICAM-1 expression on human renal tubular epithelial cells in vitro. Transplantation 1991; 51(6): 1272.
27. Maury CP, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med 1988; 166: 1132.
28. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990; 62: 3.
29. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 1991; 9: 27.
30. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 1991; 31: 859.
31. Dustin ML, Carpen O, Springer TA. Regulation of locomotion ! and cell-cell contact area by the LFA-1 and ICAM-1 adhesion receptors. J Immunol 1992; 148: 2654.
32. Hancock WdH, Whitley WD, Tullius SG, et al. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993; 56: 643.
33. Jelinek DF, Lipsky PE. Regulation of human B lymphocyte activation, proliferation and differentiation. Adv Immunol 1987; 40: 1.
34. deFranco AL. Molecular aspects of B-lymphocyte activation. Annu Rev Cell Biol 1987; 3: 143.
35. Weimer R, Pomer S, Staehler G, Opelz G. Increased T suppressor activity in renal transplant recipients with long-term stable graft function. Clin Transplant 1990; 4: 280.
36. Weimer R, Daniel V, Zimmermann R, Schimpf K, Opelz G. Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected pa tients. Blood 1991; 7: 133.
37. Weimer R, Schweighoffer T, Schimpf K, Opelz G. Helper and suppressor T-cell function in HIV-infected hemophilia patients. Blood 1989; 74: 289.
38. Weimer R, Zipperle S, Daniel V, Pomer S, Staehler G, Opelz G. IL-6 independent monocyte/B cell defect in renal transplant recipients with long-term stable graft function. Transplantation 1994; 57: 54.
39. Danzer SG, Campo C, Kunze B, Kirchner H, Rink L. Identification of HLA-DRB1 and HLA-DQB1 identical individuals by a cytokine-based mixed lymphocyte culture. Lymphokine Cytokine Res 1994; 13: 303.
40. Schmouder RL, Strieter RM, Wiggins RC, Kunkel SL. Regulation of IL-8 gene expression in human renal epithelial cells. FASEB J 1991; 5: A1708.
41. Rousset F, Garcia E, Defrance T, et al. IL-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890.
42. Llorente L, Zou W, Levy Y, et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 1995; 181: 839.
43. Defrance T, Vanhervliet B, Brière F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992; 175: 671.
44. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HD. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 1993; 178: 1097.
45. Merville P, Lambert C, Durand I, et al. High frequency of IL-10-secreting CD4+ graft-infiltrating T lymphocytes in promptly rejected kidney allografts. Transplantation 1995; 59: 1113.
46. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989; 142(11): 3857.
47. Lee MS, Wogensen L, Shizuru J, Oldstone MB, Sarvetnick N. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest 1994; 93(3): 1332.
48. Steinman J, Kaden J, May G. Failure of in vitro T-cell assays to predict clinical outcome after human kidney transplantation. J Clin Lab Anal 1994; 8: 157.
49. Herzog WR, Zanker B, Irschick E, et al. Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft. Transplantation 1987; 43: 384.
50. Deacock SJ, Lechler RI. Positive correlation of T cell sensitization with frequencies of alloreactive T helper cells in chronic renal failure patients. Transplantation 1992; 54: 338.
51. Kaminski ER, Kaminski A, Bending MR, et al. In vitro cytokine profiles and their relevance to rejection following renal transplantation. Transplantation 1995; 60: 703.
52. Schmouder RL, Kunkel SL. The cytokine response in renal allograft rejection. Nephrol Dial Transplant 1995; 10(1): 36.
53. Landay A, Gartland GL, Clement LT. Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses. J Immunol 1983; 131: 2757.
54. Clement LT, Grossi CE, Gartland GL. Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation. J Immunol 1984; 133: 2461.
55. Abo W, Gray JD, Bakke AC, Horwitz DA. Studies on human blood lymphocytes with iC3b (type 3) complement receptors. II. Characterization of subsets which regulate pokeweed mitogen-induced lymphocyte proliferation and immunoglobulin synthesis. Clin Exp Immunol 1987; 67: 544.